Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) Income towards Parent Company (2024 - 2026)

Beta Bionics' Income towards Parent Company history spans 3 years, with the latest figure at -$21.9 million for Q1 2026.

  • On a quarterly basis, Income towards Parent Company fell 35.1% to -$21.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$66.4 million, a 34.94% decrease, with the full-year FY2025 number at -$60.7 million, down 46.94% from a year prior.
  • Income towards Parent Company hit -$21.9 million in Q1 2026 for Beta Bionics, down from -$13.5 million in the prior quarter.
  • Over the last five years, Income towards Parent Company for BBNX hit a ceiling of -$8.3 million in Q1 2024 and a floor of -$21.9 million in Q1 2026.
  • Historically, Income towards Parent Company has averaged -$13.8 million across 3 years, with a median of -$13.5 million in 2025.
  • The widest YoY moves for Income towards Parent Company: up 11.42% in 2025, down 94.92% in 2025.
  • Tracing BBNX's Income towards Parent Company over 3 years: stood at -$12.1 million in 2024, then fell by 11.42% to -$13.5 million in 2025, then crashed by 62.59% to -$21.9 million in 2026.
  • Business Quant data shows Income towards Parent Company for BBNX at -$21.9 million in Q1 2026, -$13.5 million in Q4 2025, and -$14.2 million in Q3 2025.